Portfolio (Quarterly)
Guide ↗
Rhenman & Partners Asset Management AB
· CIK 0001599882| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | MDT | MEDTRONIC PLC | Healthcare | 90,000.0 | $7.8M | 0.96% | -206K | -69.6% | $86.65 | -7.1% |
| 22 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 92,900.0 | $7.0M | 0.86% | -66K | -41.4% | $75.09 | -27.1% |
| 23 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 81,627.0 | $6.9M | 0.84% | -17K | -17.2% | $83.92 | +19.1% |
| 24 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 128,100.0 | $6.2M | 0.76% | -20K | -13.2% | $48.20 | +2.9% |
| 25 | EHC | ENCOMPASS HEALTH CORP | Healthcare | 56,263.0 | $5.4M | 0.67% | -90K | -61.5% | $96.73 | +13.6% |
| 26 | AMGN | AMGEN INC | Healthcare | 15,200.0 | $5.3M | 0.66% | -21K | -57.8% | $351.85 | +1.8% |
| 27 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 313,500.0 | $4.9M | 0.60% | -224K | -41.7% | $15.50 | +53.9% |
| 28 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 239,500.0 | $4.5M | 0.55% | -124K | -34.2% | $18.64 | +7.1% |
| 29 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 16,675.0 | $4.3M | 0.53% | -8K | -33.3% | $258.32 | +35.6% |
| 30 | DOCS | DOXIMITY INC | Healthcare | 183,808.0 | $4.3M | 0.53% | -189K | -50.7% | $23.30 | -4.5% |
| 31 | RLAY | RELAY THERAPEUTICS INC | Healthcare | 360,000.0 | $3.6M | 0.44% | -100K | -21.7% | $9.95 | +96.1% |
| 32 | — | COOPER COS INC | — | 50,000.0 | $3.6M | 0.44% | -278K | -84.7% | $71.50 | — |
| 33 | DHR | DANAHER CORPORATION | Healthcare | 18,052.0 | $3.4M | 0.42% | -81K | -81.8% | $189.60 | +5.9% |
| 34 | PODD | INSULET CORP | Healthcare | 14,000.0 | $2.9M | 0.36% | -47K | -77.0% | $209.84 | -24.1% |
| 35 | STOK | STOKE THERAPEUTICS INC | Healthcare | 83,000.0 | $2.7M | 0.33% | -133K | -61.6% | $32.56 | -8.1% |
| 36 | IMCR | IMMUNOCORE HLDGS PLC | Healthcare | 85,724.0 | $2.6M | 0.32% | -68K | -44.1% | $30.15 | +15.0% |
| 37 | VCEL | VERICEL CORP | Healthcare | 70,000.0 | $2.3M | 0.28% | -47K | -40.2% | $32.17 | +43.3% |
| 38 | KURA | KURA ONCOLOGY IN | Healthcare | 271,500.0 | $2.2M | 0.27% | -600K | -68.9% | $8.13 | +39.4% |
| 39 | CI | THE CIGNA GROUP | Healthcare | 8,000.0 | $2.1M | 0.26% | -31K | -79.3% | $266.75 | +11.6% |
| 40 | BTSG | BRIGHTSPRING HEALTH SVCS INC | Healthcare | 50,000.0 | $2.1M | 0.26% | -148K | -74.8% | $42.61 | +60.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
98.9%
Technology
1.1%